Ashkon Software



FLML - Flamel Technologies S.A.

Flamel Technologies S.A. logo Flamel Technologies S.A. (FLML) is a pharmaceutical company that specializes in developing and commercializing innovative drug delivery systems. The company's products and services are used in a range of therapeutic areas, including pain management, diabetes, and rare diseases. Flamel Technologies is headquartered in Lyon, France.

Flamel Technologies had a market capitalization of approximately $92 million. The company's total revenue for the fiscal year 2020 was $94.7 million, representing an increase from $66.9 million in the previous year. Net income for the same period was $6.3 million, an improvement from a net loss of $21.2 million in the previous year.

Flamel Technologies has a strong focus on innovation, and has been recognized for its advanced drug delivery technologies and solutions. The company's products are marketed through a network of partners and distributors in the United States, Europe, and other markets around the world.

The company faces competition from other pharmaceutical companies that operate in the same therapeutic areas, as well as from emerging technologies and new market entrants. However, Flamel Technologies' strong track record of innovation, experienced management team, and strategic partnerships should position it well for continued success in the future.

Flamel Technologies' stock is listed on the NASDAQ stock exchange under the ticker symbol FLML. Investors should carefully consider their investment objectives, risk tolerance, and other factors before investing in Flamel Technologies or any other pharmaceutic




Copyright © 2000-2023, Ashkon Software LLC
Privacy Policy | Refund Policy | Disclaimer